Latest news

• FDA approves first cholera vaccine in US

  The approval also comes against the backdrop of a worldwide shortage in oral cholera vaccines, which include Valneva's Dukoral and the International Vaccine Institute's Shanchol. ... It is a live attenuated vaccine, incorporating a weakened strain of the

• Sanofi enters vaccines partnership with Sutro

  Sanofi Pasteur's vaccines currently cover 20 infectious diseases, including tuberculosis, cholera, influenza and hepatitis, and it is currently investigating a product to protect against the dengue virus.

• J&J to buy remaining shares in Crucell

  as hepatitis, influenza, typhoid and cholera.

• Kicking the habit

  Preliminary data from a phase I trial of the vaccine, which comprises a nicotine derivative conjugated to a recombinant cholera toxin B, indicated that self-reported quit rates were considerably greater

• A Lucent View

  and cholera and GlaxoSmithKline is funding (still, since 1993) an international, co-ordinated research programme to fight TB.